Segment Information

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Segment Information

Segment Information

AbbVie operates in one business segment—pharmaceutical products. The following table details AbbVie’s worldwide net revenues:

	Three months ended September 30,				Nine months ended September 30,
(in millions)	2017		2016		2017		2016
HUMIRA	$	4,701	$	4,060	$	13,535	$	11,786
IMBRUVICA	688		501		1,865		1,321
HCV	276		378		764		1,211
Lupron	201		193		605		602
Creon	215		187		596		517
Synagis	116		96		456		460
Synthroid	191		188		576		558
AndroGel	147		174		437		501
Kaletra	85		137		310		416
Sevoflurane	100		102		311		327
Duodopa	94		74		255		215
All other	181		342		767		928
Total net revenues	$	6,995	$	6,432	$	20,477	$	18,842